Assessment of clinical trials in oncology: An evaluation of 40,696 trials on ClinicalTrials.gov.
B. R. Hirsch
No relevant relationships to disclose
R. M. Califf
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Heart.org; Kowa ; Medtronic; Merck; Novartis; Sanofi ; Xoma
Stock Ownership - Nitrox
Research Funding - Amylin; Johnson & Johnson; Lilly; Merck; Novartis; Schering-Plough
A. Tasneem
No relevant relationships to disclose
K. Chiswell
No relevant relationships to disclose
J. Bolte
No relevant relationships to disclose
K. A. Schulman
Consultant or Advisory Role - Advanced Health Media; Blue Cross Blue Shield ; Forest Laboratories; GlaxoSmithKline; Johnson & Johnson; McKinsey and Company; Medtronic; Merck; Novartis; Novo Nordisk; Orexigen; Quintiles
Stock Ownership - Alnylam; Cancer Consultants; Faculty Connection
Research Funding - Actelion; Allergan; Alnylam; Amgen; Amylin; Astellas Pharma; Bristol-Myers Squibb; Inspire Pharmaceuticals; Johnson & Johnson; Kureha; Medtronic; Merck; Merck; Nabi Biopharmaceuticals; Novartis; OSI Pharmaceuticals; Sanofi ; Scios; Tengion; Theravance; Vertex
A. P. Abernethy
Consultant or Advisory Role - Amgen; Helsinn Therapeutics; Proventys
Research Funding - Alexion Pharmaceuticals; Amgen; BioVex; Bristol-Myers Squibb; Helsinn Therapeutics; KangLaiTe; Lilly; Pfizer